founders
Ronald P. Dudek, President
Dr. Mark Ma, Chief Science Officer
Dr. Mark Ma, Chief Science Officer
Ronald P. Dudek is a successful CAR T cell company serial entreprenuer. Cellergy Pharma is the fourth and most promising CAR T cell company he has founded. His third CAR T cell company, Living Pharma, the first Adapter CAR company in the world, was acquired 1.5 years after founding.
Mr. Dudek’s extensive cell therapy industry experience includes executive roles at Miltenyi Biomedicine, Juno Therapeutics, Xcyte Therapies, Aastrom Biosciences, and Miltenyi Biotec.
Ron holds an M.B.A. degree from the U.C. Berkeley Haas School of Business, and a B.S. degree in Biological Science, summa cum laude, from Fordham University. Mr. Dudek is a member of Phi Beta Kappa.
https://www.linkedin.com/in/cartcells/
Dr. Mark Ma, Chief Science Officer
Dr. Mark Ma, Chief Science Officer
Dr. Mark Ma, Chief Science Officer
Dr. Mark Ma is the inventor of Cellergy Pharma’s chimeric antigen receptors. He is the head of an immunology research laboratory at Nemours Children’s Health in Wilmington, DE. His extensive research experience has included studying T cell receptor signaling and activation, genetic modification of T cells, and T cell antigen presentation.
Prior to joining Nemours Children’s Health, Dr. Ma was an assistant professor at the world’s leading CAR T cell academic institution, the University of Pennsylvania.
Mark holds an M.B.B.S. degree from Qingdao Medical College, an M.S. degree from the Chinese Academy of Medical Sciences, and a Ph.D. degree from the University of Pennsylvania.